SCHEMBL6201152

SCHEMBL6201152

Fc1cccc(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29635658 1.00
SCHEMBL165706 1.00
Water SCHEMBL28237316 0.97
Ammonia Solution, Strong SCHEMBL27777173 0.97 MEN1 (0.52)
Hydrogen Sulfide SCHEMBL28292165 0.97
Ammonia Solution, Strong SCHEMBL4265090 0.97
Chloromethane SCHEMBL27654417 0.95 MEN1 (0.50)
Bromide SCHEMBL28196870 0.95 MEN1 (0.50)
Bromide SCHEMBL28196869 0.95 MEN1 (0.50)
Ethane SCHEMBL27840710 0.95 MEN1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012163959-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2012-12-06 WO disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed